The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
Luca Faloppi(University of Macerata), Stefano Cascinu(Vita-Salute San Raffaele University), Riccardo Giampieri(Azienda Ospedaliero-Universitaria delle Marche), Rossana Berardi(Marche Polytechnic University), Silvia Fanello(Marche Polytechnic University), Michela Cinquini(Mario Negri Institute for Pharmacological Research), Mario Scartozzi(University of Cagliari), Alessandro Bittoni(Marche Polytechnic University), Stefania Mosconi(Ospedale Papa Giovanni XXIII), C. Boni(Ospedale Santa Maria), Alberto Zaniboni(Fondazione Poliambulanza Istituto Ospedaliero), Sandro Barni, Maristella Bianconi(Marche Polytechnic University), Kalliopi Andrikou, Roberto Labianca(Ospedale Papa Giovanni XXIII), Daris Ferrari, Alberto F. Sobrero(Ospedale Policlinico San Martino), Francesco Caprioni(Ospedale Policlinico San Martino), Enrico Aitini, Valter Torri(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 46
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k